0001104659-22-100151.txt : 20220914
0001104659-22-100151.hdr.sgml : 20220914
20220914211617
ACCESSION NUMBER: 0001104659-22-100151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220816
FILED AS OF DATE: 20220914
DATE AS OF CHANGE: 20220914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULAT JAMES R
CENTRAL INDEX KEY: 0001229448
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35803
FILM NUMBER: 221244328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mallinckrodt plc
CENTRAL INDEX KEY: 0001567892
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981088325
FISCAL YEAR END: 1230
BUSINESS ADDRESS:
STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK
STREET 2: CRUISERATH, BLANCHARDSTOWN
CITY: DUBLIN 15
STATE: L2
ZIP: D15
BUSINESS PHONE: 353 1 6960000
MAIL ADDRESS:
STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK
STREET 2: CRUISERATH, BLANCHARDSTOWN
CITY: DUBLIN 15
STATE: L2
ZIP: D15
4
1
tm2225913-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-08-16
0
0001567892
Mallinckrodt plc
MNKPF
0001229448
SULAT JAMES R
675 MCDONNELL BLVD.
HAZELWOOD
MO
63042
1
0
0
0
Restricted Stock Units
2022-08-16
4
D
0
22533
0
D
Ordinary Shares
22533
26276
D
As previously disclosed, on August 16, 2022, James R. Sulat agreed to relinquish 22,533 of the restricted stock units ("RSUs") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the "MIP"). Mallinckrodt plc ("Mallinckrodt") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Mr. Sulat 26,277 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence.
This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.
/s/ Bryan M. Reasons, Attorney-in-Fact
2022-09-14